Skip to content

APOTHEEK DAEM

Active Private limited companyfounded 2001active for 25 yearsGravenbosstraat 81, 1770 LiedekerkeKBO/BCE: BE 0475.968.112

Lifetime

24 annual accounts with figures on one time axis
peak of €181,687 in 2013
€70,566▲ 59.6%
lowest -€5,224 in 2019
€44,510▲ 77.1%
peak of €341,489 in 2025
€341,489▲ 15.0%
€184,309▲ 60.0%
peak of 3 FTE in 2014
-not published
Board1 name since 2023
1 director
Owners
50%
Documentsfilings and deeds
31-08-202631 days late
2025abbreviated format
Gross margin from €44,225 to €70,566Result from €25,136 to €44,510Equity from €296,979 to €341,489Debts from €115,205 to €184,309Cash from €92,939 to €149,354

Key points

from the 2025 annual accounts

Equity

€341,489 ▲ 15.0%

APOTHEEK DAEM has made a profit without a break since 2020.

Debts

€184,309 ▲ 60.0%
Suppliers
+63,128
Taxes and wages
+5,981
The rest
-4

Debts rose by €69,104 in 2025.

Filings

24 annual accounts since 2002
AprilJune31 JulyOctober20102020

Ten of the last ten came late. The 2024 accounts came in latest, 106 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,155 companies had the same profile as APOTHEEK DAEM has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,155 companies, not a prediction for APOTHEEK DAEM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
  • 50%score equity €220,755 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0475968112
New director appointed, resigned · acts as permanent representative · “Het verlenen van strategisch, bedrijfseconomisch, technisch, financieel en juridisch advies, management…” (deed in Dutch) · General meeting of 01-06-2023 · Gazette deed
Capital increase of €90,000 to €108,600 The capital rose from €18,600 to €108,600 · Contribution by · General meeting of 13-01-2014 · Gazette deed
First establishment Gravenbosstraat 81, Liedekerke
All 37 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK DAEM Liedekerke €525,798 €70,566 64.9% -
PHARMA LOVENJOEL Bierbeek €482,587 €76,302 17.2% -
APOTHEEK VAN CAUSBROECK Dendermonde €517,688 €67,311 2.2% -
APOTHEEK VAN DE WALLE-BLANCQUAERT Ghent €520,003 €73,516 32.0% -
APOTHEEK VAN HOORICKX Temse €579,253 €75,372 20.3% 0.5
BILOBA KESSEL-LO Leuven €611,082 €75,136 2.4% -
GILIS-SEGERS Tienen €545,887 €68,877 70.6% -

These companies have the same main activity as APOTHEEK DAEM: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €483,000 and €611,000, founded between 1996 and 2004.

Official details

Source: KBO
Status
Active since 31-10-2001Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2024
Establishment unit
2.095.460.9101770 Liedekerke, since 19-12-2001
Financial year end
31 December
Peppol
Reachable since 21-10-2026
Company details

Annual accounts 2025

≈ €340,000estimated
€525,798▲ 27.6%
Filing
Filed on 31-08-2026
Financials

Insights on APOTHEEK DAEM

APOTHEEK DAEM files the abbreviated format. That format states no turnover. The gross margin fell from €90,801 in 2002 to €70,566 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK DAEM

What is the company number of APOTHEEK DAEM?
The company number of APOTHEEK DAEM is 0475.968.112. The VAT number is the same number with BE in front: BE 0475.968.112.
Where is APOTHEEK DAEM based?
The registered office is at Gravenbosstraat 81, 1770 Liedekerke.Company details
What does APOTHEEK DAEM do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK DAEM?
APOTHEEK DAEM is a private limited company (BV).
When was APOTHEEK DAEM founded?
APOTHEEK DAEM was founded on 31-10-2001.
Is APOTHEEK DAEM still active?
Yes, APOTHEEK DAEM is an active enterprise in the KBO register.
How many employees does APOTHEEK DAEM have?
APOTHEEK DAEM had an average of 0.4 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK DAEM fall under?
In its 2024 annual accounts, APOTHEEK DAEM states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK DAEM?
The turnover in financial year 2025 is about €340,000. This figure is estimated from the gross margin of €70,566 and 78 comparable companies (NACE 477). It probably lies between €170,000 and €500,000.
Is APOTHEEK DAEM profitable?
In financial year 2025, APOTHEEK DAEM made a profit of €44,510.
Where can I find the annual accounts of APOTHEEK DAEM?
APOTHEEK DAEM filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK DAEM due?
APOTHEEK DAEM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.